Top news from MedWatch this week
Monday
WS Audiology lives up to topline growth expectations – sees challenges ahead
WS Audiology CEO expects market slowdown to continue in coming months
WSA CEO says Kirkland Signature absence at Costco has helped
Tuesday
Axsome races for Alzheimer’s agitation approval
Novo Nordisk moves digital unit, appoints new head
Eisai and Biogen plunge after report of second death in groundbreaking Alzheimer’s drug trial
Ambu raises prices, drops discounts, and hopes for customer understanding
Wednesday
Retention, retention, retention – Danish life science firms shower employees in extra benefits
Novo Nordisk to test best-selling substance in stroke indication
Pharmacosmos tight-lipped on competitor’s Chinese market nod
Thursday
Potential Demant divestment raises competition concerns
FDA approves Ferring microbiotica-based treatment
Analyst proposes four solutions as GN battles with ghosts of debts past
Friday
FDA confirms rejection of Y-mabs’ cancer drug
